Skip to main content

Microdialysis monitoring for improved health care!

M Dialysis AB develops and markets clinical microdialysis solutions for advanced clinical research and general intensive care usage. Our microdialysis solutions are used across the globe by caregivers and researchers for improved health care.

Company Overview

M Dialysis AB is a Swedish medical device and research company that is an offshoot from CMA Microdialysis AB that was founded in 1984.

M Dialysis’s unique and market leading solutions are developed, produced and sold to clinicians and researchers to enable optimized patient care and accelerated drug development. The complete line of microdialysis instruments, consumables and computer software are used globally by universities, hospitals and pharmaceutical companies as unique tools for in vivo sampling and monitoring of organs and tissues.

The core competence lies within solutions based on the Microdialysis technique. The products are produced in Sweden under ISO 13485 and according to FDA standards. With a highly specialized and skilled staff, consumables are manufactured in a Class 8 clean room environment.

The head office is located in Stockholm, Sweden, with a subsidiary north of Boston, USA.

M Dialysis has distributors across the globe, responsible for local sales, service and support.

M Dialysis develops, produces and markets tissue monitoring solutions for neuro and reconstructive surgery. The company also offers clinical research solutions for many other applications within General Intensive Care, Liver & Gastrointestinal surgery, Metabolic research and Drug Monitoring. The Product portfolio is mainly based on the ISCUSflex platform and a broad range of tissue and peripherial blood Microdialysis catheters.

Ownership and Governance

M Dialysis AB is a Swedish limited company and is represented in the USA through the subsidiary M Dialysis Inc. The CEO is Olof Nord, the former CEO of Dipylon Medical AB


The concept of Microdialysis was born in the early 1970’s. While examining the cross-section of a blood vessel among fluorescent nerve endings, Professor Urban Ungerstedt of the Karolinska Institute in Stockholm had the idea of using a dialysis tube as “an artificial blood capillary”, in order to monitor chemical events in the tissue, see Microdialysis technique.

The first paper on Microdialysis was published in 1974. Since then, more than 16.500 scientific papers have been published on the technique.

Tomorrow Today